You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Prior Cardiovascular Interventions Are Not Associated With Worsened Clinical Outcomes in Patients With Symptomatic Atherothrombosis

Boden, William E. MD*; Cherr, Gregory S. MD†; Eagle, Kim A. MD‡; Cannon, Christopher P. MD§; Califf, Robert M. MD¶; Hirsch, Alan T. MD∥; Alberts, Mark J. MD**; Criqui, Michael MD, MPH††; Creager, Mark A. MD‡‡; Massaro, Joseph M. PhD§§; D'Agostino, Ralph B. Sr PhD¶¶; Steg, P. Gabriel MD∥∥; Bhatt, Deepak L. MD, MPH***; on behalf of the REACH Registry Investigators

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine:
doi: 10.1097/HPC.0b013e3181e7f93e
Original Article
Abstract

To assess the effect of prior cardiovascular interventions on long-term clinical outcomes in patients with symptomatic atherothrombosis, the risk factor profiles, treatment patterns, and 24-month outcomes of patients in the United States with and without prior cardiovascular intervention (catheter-based, surgical, or lower-limb amputation) enrolled in the global REACH (REduction of Atherothrombosis for Continued Health) Registry were compared. Of the 17,521 US outpatients aged ≥45 years with established coronary artery disease, cerebrovascular disease, or peripheral artery disease enrolled in the REACH Registry between December 1, 2003 and June 1, 2004 who had ≥1 follow-up visit, 11,925 (68.1%) had a previous cardiovascular intervention. Prior intervention was most common in patients with coronary artery disease (76.7%) and least common in patients with cerebrovascular disease (14.6%) at baseline. Patients with prior cardiovascular intervention were significantly more likely to be taking antihypertensive, antithrombotic, or lipid-lowering therapies than those without prior intervention (P < 0.0001 for each therapy). However, 24-month Kaplan-Meier event rates for the composite outcome of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke were similar between patients with and without prior intervention (9.10% vs. 9.00%; P = 0.49). Thus, in the US REACH Registry, prior cardiovascular intervention was not associated with an increased risk of subsequent cardiovascular ischemic events during follow-up. Patients without prior cardiovascular intervention had a lower intensity of risk factor modification at baseline and appear to represent an at-risk, undertreated population.

Author Information

From the *Department of Cardiology, Buffalo General and Millard Fillmore Hospitals and Division of Cardiovascular Medicine, SUNY at Buffalo Schools of Medicine & Public Health, Buffalo, NY; †Department of Surgery, Buffalo General Hospital and SUNY at Buffalo School of Medicine, Buffalo, NY; ‡University of Michigan Cardiovascular Center, Ann Arbor, MI; §TIMI Study Group, Harvard Medical School and Cardiovascular Division, Brigham & Women's Hospital, Boston, MA; ¶Duke Translational Medicine Institute and Division of Cardiology, Duke University Medical Center, Durham, NC; ∥Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN; **The Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital, Chicago, IL; ††Division of Preventive Medicine, University of California San Diego School of Medicine, San Diego, CA; ‡‡Cardiovascular Division, Brigham & Women's Hospital, Boston, MA; §§Department of Biostatistics, Boston University School of Public Health and Harvard Clinical Research Institute, Boston, MA; ¶¶Department of Mathematics and Statistics, Boston University and Harvard Clinical Research Institute, Boston, MA; ∥∥INSERM U-698, Recherche Clinique en Athérothrombose, Université Paris 7 AP-HP, Paris, France; and ***Department of Cardiology, VA Boston Healthcare System; Integrated Interventional Cardiovascular Program, Brigham & Women's Hospital; and TIMI Study Group, Harvard Medical School; Boston, MA.

This manuscript was written and edited by the authors, who take full responsibility for its content. The first draft was written by Dr. Boden and Dr. Cherr.

Reprints: William E. Boden, MD, Division of Cardiology, Buffalo General Hospital, SUNY at Buffalo School of Medicine, 100 High St, Buffalo, NY 14203. E-mail: wboden@kaleidahealth.org.

© 2010 Lippincott Williams & Wilkins, Inc.